This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: University of Colorado. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2019
Title: The Innovative Contributions of Sarath Yandrapu
Introduction
Sarath Yandrapu is a notable inventor based in Christianburg, VA (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic peptides. With a total of 2 patents, his work focuses on addressing degenerative disorders through innovative formulations.
Latest Patents
Yandrapu's latest patents include the development of LEDGF peptides and formulations for the treatment of degenerative disorders. These LEDGF peptides exhibit anti-protein aggregation activity and provide methods of use that demonstrate their ability to treat degenerative diseases. The peptides are particularly effective against various cellular stresses, including oxidative stress and protein-aggregation stress. Additionally, Yandrapu has developed extended release formulations, including those suitable for ophthalmic administration, enhancing the potential applications of his work.
Career Highlights
Sarath Yandrapu is affiliated with the University of Colorado, where he continues to advance his research in peptide therapeutics. His innovative approach has garnered attention in the scientific community, contributing to the understanding and treatment of complex diseases.
Collaborations
Yandrapu collaborates with esteemed colleagues such as Uday Bhaskar Kompella and Rinku Baid. Their combined expertise fosters a productive research environment, leading to groundbreaking discoveries in the field.
Conclusion
Sarath Yandrapu's contributions to the development of LEDGF peptides represent a significant advancement in the treatment of degenerative disorders. His innovative work continues to inspire and pave the way for future research in biomedical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
